California State Teachers Retirement System (CalSTRS)’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,193
Closed -$6.19K 3111
2025
Q1
$6.19K Sell
6,193
-48,264
-89% -$82.6K ﹤0.01% 2883
2024
Q4
$577K Buy
54,457
+48,362
+793% +$580K ﹤0.01% 2041
2024
Q3
$80.5K Hold
6,095
﹤0.01% 2412
2024
Q2
$59.9K Buy
6,095
+4,599
+307% +$47.6K ﹤0.01% 2422
2024
Q1
$20.6K Sell
1,496
-953
-39% -$15.4K ﹤0.01% 2695
2023
Q4
$41.8K Buy
+2,449
New +$30.1K ﹤0.01% 2663

Other funds holding NMRA

California State Teachers Retirement System (CalSTRS)'s NMRA Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Neumora Therapeutics (NMRA) in Q2 2025, closing a stake of 6,193 shares — an estimated $6.19K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in NMRA in Q4 2023 and held it in 6 quarters. The position peaked at $577K in Q4 2024. 98 funds tracked by Wall St. Rank hold NMRA as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Neumora Therapeutics position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 6,193 Neumora Therapeutics shares in Q2 2025, an estimated $6.19K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Neumora Therapeutics in Q4 2023 and held it in 6 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Neumora Therapeutics position peaked at $577K in Q4 2024.
  • 98 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.